Kaplan Lester J Ph D - Net Worth and Insider Trading
Kaplan Lester J Ph D Net Worth
The estimated net worth of Kaplan Lester J Ph D is at least $150,110 dollars as of 2024-11-10. Kaplan Lester J Ph D is the Director of ACADIA Pharmaceuticals Inc and owns about 8,500 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $150,110. Details can be seen in Kaplan Lester J Ph D's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kaplan Lester J Ph D has not made any transactions after 2014-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kaplan Lester J Ph D
Kaplan Lester J Ph D Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kaplan Lester J Ph D owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Kaplan Lester J Ph D’s form 4 insider trades.
Insider Ownership Summary of Kaplan Lester J Ph D
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2014-09-02 | director |
Kaplan Lester J Ph D Latest Holdings Summary
Kaplan Lester J Ph D currently owns a total of 1 stock. Kaplan Lester J Ph D owns 8,500 shares of ACADIA Pharmaceuticals Inc (ACAD) as of September 2, 2014, with a value of $150,110.
Latest Holdings of Kaplan Lester J Ph D
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2014-09-02 | 8,500 | 17.66 | 150,110 |
Holding Weightings of Kaplan Lester J Ph D
Kaplan Lester J Ph D Form 4 Trading Tracker
According to the SEC Form 4 filings, Kaplan Lester J Ph D has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 57,692 shares on September 2, 2014, which brought Kaplan Lester J Ph D around $2 Million.
Insider Trading History of Kaplan Lester J Ph D
- 1
Kaplan Lester J Ph D Trading Performance
Kaplan Lester J Ph D Ownership Network
Ownership Network List of Kaplan Lester J Ph D
Ownership Network Relation of Kaplan Lester J Ph D
Kaplan Lester J Ph D Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Kaplan Lester J Ph D is the director of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Kaplan Lester J Ph D made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Kaplan Lester J Ph D Mailing Address
Above is the net worth, insider trading, and ownership report for Kaplan Lester J Ph D. You might contact Kaplan Lester J Ph D via mailing address: 2525 Dupont Drive, Irvine Ca 92715.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
